Leslie Brown
Family · Levittown, PANPI 1700039070
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 77 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $855 and has fallen 73.9% since, to $223 in 2025.
Across 77 payments — averaging $32.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$492
- Novo Nordisk$363
- Lilly USA, LLC$286
- AbbVie$227
- Pfizer$219
- E.r. Squibb & Sons, L.L.C.$125
- plus $802 from 18 others
What the payments were for
- Food & beverage$2,514100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 7 | $492 |
| Novo Nordisk | 10 | $363 |
| Lilly USA, LLC | 11 | $286 |
| AbbVie | 6 | $227 |
| Pfizer | 6 | $219 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $99 |
| Bayer | 4 | $73 |
| Amgen | 5 | $65 |
| Novartis | 4 | $60 |
| GSK | 3 | $58 |
| Coloplast | 1 | $56 |
| Amarin Pharma, Inc. | 2 | $30 |
| Radius Health, Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $29 |
| Merck | 2 | $29 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Insightec,inc | 1 | $20 |
| Exact Sciences | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,514 in reported general payments places this provider in the 85th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 60 | $328 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 28 | $293 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $275 |
| Methylprednisolone | 27 | $195 |
| Cefdinir | 14 | $174 |
| Mupirocin | 26 | $157 |
| Prednisone | 66 | $100 |
| Fluticasone Propionate | 13 | $73 |
| Triamcinolone Acetonide | 15 | $68 |
| Dexamethasone | 17 | $66 |
| Cephalexin | 14 | $66 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 11 | $62 |
| Azithromycin | 11 | $55 |
Paid to pharmacies, not to this prescriber.
Other family in Levittown
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
- Patricia HabdasPittsburgh$83K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.